This is the information currently posted on the the clinical trails gov website regarding their diabetic foot ulcer study. Hopefully we'll get an update in the near future.
Study Type:
Interventional (Clinical Trial)
1
EstimatedEnrollment:
138 participants
2
Allocation:
Randomized
3
Intervention Model:
Parallel Assignment
4
Masking:
None (Open Label)
5
Primary Purpose:
Treatment
6
Official Title:
A Prospective, Multicenter, Open Label, Randomized, Controlled Clinical Study Evaluating the Effect of NovoSorb ® SynPath™ Dermal Matrix Compared to Standard of Care (SOC) In the Treatment of Nonresponsive, Chronic Diabetic Foot Ulcers.
7
ActualStudy Start Date:
July 10, 2022
8
EstimatedPrimary Completion Date:
December 1, 2023
9
EstimatedStudy Completion Date:
March 1, 2024
PNV Price at posting:
$1.40 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)